INCB099318
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB099318, covering 2025-10-16 to 2025-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors [Phase 1]